← FDA Drug Approvals (Drugs@FDA)

CEPHALEXIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2026-06-09

Drug application

FDA Application #

ANDA213568

Application type

Abbreviated New Drug Application (Generic)

Brand name

CEPHALEXIN

Generic name

CEPHALEXIN

Active ingredients

CEPHALEXIN

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2026-06-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown